FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

33480911000001104: Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Oct 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100901701000001116 Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100901801000001113 Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) Is a Buprenorphine 10micrograms/hour patches true Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) Has active ingredient Buprenorphine true Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) Has specific active ingredient Buprenorphine true Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) Is a Sevodyne true Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) Has manufactured dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Has AMP True Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start